| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| JXHL1900085 | 达格列净沙格列汀片 | dapagliflozin;saxagliptin | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2019-05-09 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd;Astrazeneca Canada Inc | In Review | 2019-05-08 | view |
| JXHL1900086 | 达格列净沙格列汀片 | dapagliflozin;saxagliptin | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2019-05-09 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd;Astrazeneca Canada Inc | In Review | 2019-05-08 | view |